Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Journal of Laboratory Medicine and Quality Assurance
>
2011
>
33
Volume:
33
1. Evaluation of HUBI-QUANPRO Point-of-Care Testing for Cardiac Markers.
Page:75—82
2. Evaluation of Alterations in Homocysteine Levels According to the Delayed Initiation Time of Centrifugation.
Page:71—74
3. Preliminary Evaluation of the URiSCAN SUPER and Usefulness of a New Urine Reagent Strip to Detect Ascorbic Acid.
Page:63—69
4. Conflict of Interest.
Page:57—61
5. Analysis of the Patients with Indeterminate Results by Anti-HIV Western Blot Assay: Experience of a University Hospital During Recent 5 Years in Korea.
Page:49—55
6. Evaluation of two Real-Time PCR Assays for the Detection of Chlamydia trachomatis.
Page:43—47
7. Use of Immunochromatographic Assays for Identification of Mycobacterium tuberculosis Complex from Broth Cultures.
Page:39—42
8. Detection of Varicella-Zoster Virus (VZV) by Nested Polymerase Chain Reaction.
Page:31—37
9. Evaluation of the i-Smart 30 Point-of-Care Analyzer for Use in Clinical Laboratory Settings.
Page:25—30
10. Evaluation of the Analytical Performance of NOVA StatStrip(R) Blood Glucometer in a Peritoneal Dialysis Setting.
Page:17—24
11. A Serial Study of Hematologic Change in Burned Patients.
Page:9—16
12. Detection of Rare Cancer Cells in the Blood by RNA Extraction of Filtered Mononuclear Cells and Reverse Transcription-PCR.
Page:111—118
13. Comparison of Two Automated Immunoassays for the Detection of Anti-Hepatitis A Virus Total Immunoglobulin and IgM.
Page:103—109
14. Analysis of Positive Results in Mediace Rapid Plasma Reagin and Treponema pallidum Latex Agglutination at a University Hospital.
Page:95—101
15. Interpretation of Weak-Positive Bands in a Multiplex PCR Using Seeplex RV12 ACE Detection Kit.
Page:89—93
16. Performance Evaluation of Chemiluminescent Immunoassay for Erythropoietin and Establishment of Reference Interval in Korean Population.
Page:83—88
17. Postchemotherapy Changes in Cytokine Levels and Their Correlation with Hematological Parameters in Patients with Vivax Malaria.
Page:1—8
